# Ulrich Specks

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ulrich-specks/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,543 |
| Field | Vasculitis and related conditions |
| h-index | 84 |
| i10-index | 270 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5012967877 |
| ORCID iD | 0000-0002-6559-1206 |
| Works | 516 |

## Researcher papers

Showing 12 of 19.

- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of-2/)
- [Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis](https://scholariq.org/papers/rituximab-versus-cyclophosphamide-for-anca-associated-vasculitis/)
- [2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides](https://scholariq.org/papers/2012-revised-international-chapel-hill-consensus-conference-nomenclature-of/)
- [Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis](https://scholariq.org/papers/mepolizumab-or-placebo-for-eosinophilic-granulomatosis-with-polyangiitis/)
- [ANCA-associated vasculitis](https://scholariq.org/papers/anca-associated-vasculitis/)
- [Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis](https://scholariq.org/papers/plasma-exchange-and-glucocorticoids-in-severe-anca-associated-vasculitis/)
- [Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis](https://scholariq.org/papers/efficacy-of-remission-induction-regimens-for-anca-associated-vasculitis/)
- [Anticytoplasmic Autoantibodies: Their Immunodiagnostic Value in Wegener Granulomatosis](https://scholariq.org/papers/anticytoplasmic-autoantibodies-their-immunodiagnostic-value-in-wegener/)
- [Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management](https://scholariq.org/papers/eosinophilic-granulomatosis-with-polyangiitis-churg-strauss-egpa-consensus-task/)
- [A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score](https://scholariq.org/papers/a-disease-specific-activity-index-for-wegener-s-granulomatosis-modification-of/)
- [Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis](https://scholariq.org/papers/revised-2017-international-consensus-on-testing-of-ancas-in-granulomatosis-with/)
- [Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy](https://scholariq.org/papers/response-of-wegener-s-granulomatosis-to-anti-cd20-chimeric-monoclonal-antibody/)

## Researcher topics

- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Coagulation, Bradykinin, Polyphosphates, and Angioedema](https://scholariq.org/topics/coagulation-bradykinin-polyphosphates-and-angioedema/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.